These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6428981)

  • 61. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
    Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of omeprazole on gastric acid secretion and plasma gastrin.
    Olbe L; Cederberg C; Lind T; Olausson M
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
    Simon B; Müller P; Hartmann M; Bliesath H; Lühmann R; Huber R; Bohnenkamp W; Wurst W
    Z Gastroenterol; 1990 Sep; 28(9):443-7. PubMed ID: 2177296
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of enkephalin and naloxone on gastric acid and serum gastrin and pancreatic polypeptide concentrations in humans.
    Konturek SJ; Kwiecień N; Obtułowicz W; Swierczek J; Bielański W; Oleksy J; Coy DH
    Gut; 1983 Aug; 24(8):740-5. PubMed ID: 6409709
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure.
    Howden CW; Payton CD; Meredith PA; Hughes DM; Macdougall AI; Reid JL; Forrest JA
    Eur J Clin Pharmacol; 1985; 28(6):637-40. PubMed ID: 4065187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phytohaemagglutinin inhibits gastric acid but not pepsin secretion in conscious rats.
    Kordás K; Szalmay G; Bardocz S; Pusztai A; Varga G
    J Physiol Paris; 2001; 95(1-6):309-14. PubMed ID: 11595455
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Omeprazole-like compounds on histamine-stimulated acid and peptic secretions in conscious dog and cat.
    Chiavarini M; Barocelli E; Ballabeni V; Razzetti R; Impicciatore M
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):429-36. PubMed ID: 1482561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fade and tachyphylaxis of gastric acid secretory response to pentagastrin in rat isolated gastric mucosa.
    Hirst BH; Holland J; Parsons ME; Price CA
    Br J Pharmacol; 1988 Dec; 95(4):1047-56. PubMed ID: 3219480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of urogastrone on gastric secretion and serum gastrin concentration in patients with duodenal ulceration.
    Koffman CG; Elder JB; Ganguli PC; Gregory H; Geary CG
    Gut; 1982 Nov; 23(11):951-6. PubMed ID: 6813198
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of carbacholine and urecholine on pentagastrin-stimulated gastric secretion in healthy subjects.
    Roland M; Berstad A; Liavåg I
    Scand J Gastroenterol; 1975; 10(4):357-62. PubMed ID: 239447
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histamine and duodenal ulcer: effect of omeprazole on gastric histamine in patients with duodenal ulcer.
    Man WK; Thompson JN; Baron JH; Spencer J
    Gut; 1986 Apr; 27(4):418-22. PubMed ID: 2420686
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients.
    Cederberg C; Lind T; Röhss K; Olbe L
    Digestion; 1992; 53(3-4):171-8. PubMed ID: 1291405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Smoking impairs therapeutic gastric inhibition.
    Boyd EJ; Wilson JA; Wormsley KG
    Lancet; 1983 Jan; 1(8316):95-7. PubMed ID: 6129458
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
    Andersson T; Röhss K; Bredberg E; Hassan-Alin M
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1563-9. PubMed ID: 11563995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current status of acid pump antagonists (reversible PPIs).
    Wurst W; Hartmann M
    Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of omeprazole paste on gastric acid secretion in horses.
    Daurio CP; Holste JE; Andrews FM; Merritt AM; Blackford JT; Dolz F; Thompson DR
    Equine Vet J Suppl; 1999 Apr; (29):59-62. PubMed ID: 10696296
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oral pharmacokinetics of omeprazole.
    Howden CW; Meredith PA; Forrest JA; Reid JL
    Eur J Clin Pharmacol; 1984; 26(5):641-3. PubMed ID: 6468483
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exogenous prostaglandins and gastric secretion in the cat.
    Baker R; Jaffe BM; Reed JD; Shaw B; Venables CW
    J Physiol; 1978 May; 278():441-50. PubMed ID: 353255
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer.
    Hirschowitz BI
    Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.